机译:噻唑烷二酮类药物和膀胱癌的人类研究进展
Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan,Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan,Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei (100), Taiwan;
Bladder cancer; epidemiological study; pioglitazone; rosiglitazone; thiazo-lidinediones; type 2 diabetes;
机译:Re:噻唑烷二酮和膀胱癌的相关风险:系统审查和荟萃分析
机译:Re:噻唑烷二酮和膀胱癌的相关风险:系统审查和荟萃分析
机译:回复:噻唑烷二酮类药物和膀胱癌的相关风险:系统评价和荟萃分析
机译:新英格兰膀胱癌研究中膀胱癌风险的时空分析
机译:评估人原代和癌性膀胱细胞中硝酸盐,二甲双胍和AMPK抑制剂多西吗啡的含量
机译:噻唑烷二酮类药物和相关的膀胱癌风险:系统评价和荟萃分析
机译:噻唑烷二酮类药物和膀胱癌的相关风险:系统评价和荟萃分析
机译:人乳腺癌和膀胱癌的标志物评估